The "medical community" evening news, do not miss every medical hotspot.
Four asymptomatic infected people were found in Luoyang, Henan
According to the news released by Luoyang, on December 31, 2021, the Xin'an County People's Hospital of Luoyang City, Henan Province, found 2 asymptomatic infected people with new crown pneumonia in a routine nucleic acid test. Luoyang City immediately launched an emergency mechanism, quickly carried out circulation adjustment, testing, isolation, treatment, elimination and other related work, and subsequently found 2 asymptomatic infected people.
At present, the 4 asymptomatic infected people and their close contacts and sub-close contacts have been implemented for centralized isolation for medical observation, and their places of residence and activity areas have been closed and managed. Xin'an County has carried out nucleic acid testing for all employees throughout the county, and the personnel involved in other cities and counties have been sent to the relevant areas for investigation. Further circulation work is underway, and the relevant information will be announced in a timely manner. (Released by Luoyang)
The first batch of national traditional Chinese medicine comprehensive reform demonstration zones have come
According to Xinhua News Agency reported on December 31, Shanghai, Zhejiang, Jiangxi, Shandong, Hunan, Guangdong, Sichuan and other seven provinces were the first to be approved to build a national demonstration zone for comprehensive reform of traditional Chinese medicine. The National Demonstration Zone for comprehensive reform of traditional Chinese medicine takes provinces (autonomous regions and municipalities directly under the central government) as the main body of construction, and encourages the first trial in the service model, industrial development, and quality supervision of traditional Chinese medicine. (Xinhua News Agency)
The woman had abdominal pain for 8 years and had a surgical needle removed from her stomach
In 2013, Ms. Gu of Meizhou, Guangdong Province, underwent minimally invasive surgery at Meizhou People's Hospital due to uterine fibroids, and often felt lower abdominal pain after surgery, until December this year due to a sprained waist, X-ray examination found that there was metal in the abdomen, suspected of stitches left over from surgery.
The Meizhou Municipal Health Bureau has intervened after learning of the incident. The staff of meizhou municipal health bureau said that the hospital has been contacted to arrange for removal surgery, and the patient can conduct medical malpractice appraisal according to relevant regulations and ask the hospital for compensation. On December 29, Ms. Gu had undergone surgery to remove the metal object. (N video)
Hainan will introduce "good deans" and "good doctors", and the settlement fee will be up to 600,000 yuan
On December 31, the "Hainan Provincial Work Plan for Introducing "Good Presidents" and "Good Doctors" (2021-2025)" released on the official website of the Hainan Provincial People's Government mentioned that during the "14th Five-Year Plan" period, Hainan will introduce 25 "good presidents" (including principal and deputy posts) and 300 "good doctors".
Those who have signed a contract for more than 8 years (including 8 years) will be paid a one-time settlement fee after formal appointment. The specific standards are: 600,000 yuan for the "good president" of the tertiary hospital; 500,000 yuan for the "good president" of the secondary hospital; 500,000 yuan for the "good doctor" of the tertiary hospital and the provincial public health institution; and 400,000 yuan for the "good doctor" of the secondary hospital and the city and county public health institution. Where talents are introduced that meet the criteria for identifying Class A talents, Class B talents, and Class C talents, an additional 200,000 yuan of settlement fees will be awarded according to the specific circumstances. In addition, special subsidies are also issued in the first 5 years, and are issued in grades according to the assessment results after the annual assessment every year, up to a maximum of 100,000 yuan. (Official website of The People's Government of Hainan Province)
Newborns suffer from rare skin diseases such as being burned by boiling water
Twenty days ago, the Second Affiliated Hospital of Xi'an Jiaotong University received a child with a rare hereditary skin disease, due to genetic defects caused by a large area of trauma ulceration of his skin, revealing pink tender flesh, as if burned by boiling water, looking shocking. According to the doctor, the child was diagnosed with epidermolysis bullosa and needed to undergo skin reconstruction treatment, because she needed to undergo the peeling process, also known as "butterfly baby". The most difficult part of the treatment is the nursing work, under the careful care of the medical staff, there is no infection, and the baby is about to be discharged. (White Deer Video)
Gansu Province has realized the interconnection and mutual recognition and sharing of hospital examination results throughout the province
According to lanzhou daily reported on December 30, in accordance with the work idea of "small incision, big improvement", Gansu Province has promoted the realization of 7 clinical test results, 5 ultrasound imaging results, and 7 radiographic test results throughout the province.
Up to now, 234 medical institutions in the province have achieved mutual recognition of clinical test results, 252 have achieved mutual recognition of ultrasound test results, and 176 have achieved mutual recognition of radiological imaging results, which has become a unique province in the country and the earliest province to achieve mutual recognition and sharing of inspection results at the provincial level and in the province. (Lanzhou Daily)
The third in the world! Domestic COVID-19 oral drugs were approved in Uzbekistan
On December 30, local time, the domestic new crown oral drug VV116 has been authorized for emergency use in Uzbekistan. As a result, VV116 became the third covid-19 oral drug approved for marketing in the world.
It is understood that VV116 is a candidate drug for oral nucleoside anti-new coronavirus jointly developed by the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, the Wuhan Institute of Virology of the Chinese Academy of Sciences and other domestic scientific research institutions, and at present, VV116 has entered the clinical trial stage in China. (21st Century Business Herald, Observer Network)
Source: Medical community comprehensive collation
Editor-in-charge: Zheng Huaju
Proofreader: Zang Hengjia
Plate making: Xue Jiao